Get startedLog in
    Picture of Cereno Scientific AB logo

    CRNO B — Cereno Scientific AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Cereno Expects PAH Study Completion During Q2 2024

    Picture of Cereno Scientific AB logoCereno Scientific AB
    17/11/2023 07:38
    Nov 17 (Reuters) - Cereno Scientific AB  CRNOSb.ST :
    * CERENO SCIENTIFIC REPORTS SIGNIFICANT PROGRESS AND A
TIMELINE
ADJUSTMENT IN THE PHASE II STUDY OF CS1 IN RARE DISEASE PAH
    * UPDATED STUDY TIMELINE NOW EXPECTS STUDY COMPLETION AND
TOP-LINE
RESULTS DURING Q2 2024

Source text for Eikon:  ID:nWkr34vGts 
Further company coverage:  CRNOSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Cereno Scientific AB

    See all news